SScience Read More New OpenABE gene editor improves editing efficiency by up to 36 timesJuly 30, 2026 A joint research team led by Professor Daesik Kim (Department of Medicine, Sungkyunkwan University), along with Professor Yong-Sub…
HHealthcare Read More The Startup Using AI To Make Hearing Aids BetterJuly 30, 2026 In this week’s edition of InnovationRx, we look at Fortell’s efforts to make a better hearing aid, Abby…
TTechnology Read More SynGenSys makes key appointments to strengthen senior commercial and scientific teamsJuly 22, 2026 SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance…
TTechnology Read More Can ultrasound treat Duchenne? Sonothera raises millions to find outJuly 17, 2026 For the last year, a small California startup has been making extraordinary claims about the ability of its…
HHealth Read More Weill Cornell Medicine receives federal grant to study new gene therapy for Alzheimer’s diseaseJuly 8, 2026 The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth…
HHealth Read More New gene therapy strategy uses the brain’s own glymphatic transport system for drug deliveryJuly 8, 2026 A new study describes a gene therapy strategy that uses the brain’s own glymphatic transport system to distribute…
SScience Read More Synthetic Human Chromosomes ExplainedJuly 1, 2026 IntroductionTechnologies enabling synthetic chromosomesApplications in research and medicineEthical and safety considerationsFuture outlookReferencesFurther reading From synthetic chromosomes and recoded…
HHealth Read More Gene therapy successfully treats deadly childhood liver disease in miceJune 19, 2026 A new gene therapy has been used to successfully treat a deadly childhood liver disease using mice that…
HHealthcare Read More First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicineJune 18, 2026 Jun 11 2026 An eight-month-old baby from Israel has become the first human ever to receive an experimental…
HHealth Read More Renowned physician‑scientist to lead Houston Methodist’s cell and gene therapy researchJune 13, 2026 Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has been tapped to lead…
HHealthcare Read More Gene therapies have high price tags. A financing model could helpJune 8, 2026 A new class of medicines is transforming health care. Gene therapies can now cure diseases like sickle cell…
MMedication Read More Regeneron (REGN) Says EMA Accepted Review for Otarmeni ApplicationJune 7, 2026 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On…